Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP222603.RAsswML4jAZ1GvYVxV8G4q2vvHclTUjNBsUKWx8sb3rn0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP222603.RAsswML4jAZ1GvYVxV8G4q2vvHclTUjNBsUKWx8sb3rn0130_assertion type Assertion NP222603.RAsswML4jAZ1GvYVxV8G4q2vvHclTUjNBsUKWx8sb3rn0130_head.
- NP222603.RAsswML4jAZ1GvYVxV8G4q2vvHclTUjNBsUKWx8sb3rn0130_assertion description "[In these hematopoietic cell lines, the vectors that contained ADA controlled by either the Moloney murine leukemia virus promoter (LASN) or the cytomegalovirus promoter (LNCA) expressed ADA at much higher levels than the other vectors tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222603.RAsswML4jAZ1GvYVxV8G4q2vvHclTUjNBsUKWx8sb3rn0130_provenance.
- NP222603.RAsswML4jAZ1GvYVxV8G4q2vvHclTUjNBsUKWx8sb3rn0130_assertion evidence source_evidence_literature NP222603.RAsswML4jAZ1GvYVxV8G4q2vvHclTUjNBsUKWx8sb3rn0130_provenance.
- NP222603.RAsswML4jAZ1GvYVxV8G4q2vvHclTUjNBsUKWx8sb3rn0130_assertion SIO_000772 2752148 NP222603.RAsswML4jAZ1GvYVxV8G4q2vvHclTUjNBsUKWx8sb3rn0130_provenance.
- NP222603.RAsswML4jAZ1GvYVxV8G4q2vvHclTUjNBsUKWx8sb3rn0130_assertion wasDerivedFrom befree-20150227 NP222603.RAsswML4jAZ1GvYVxV8G4q2vvHclTUjNBsUKWx8sb3rn0130_provenance.
- NP222603.RAsswML4jAZ1GvYVxV8G4q2vvHclTUjNBsUKWx8sb3rn0130_assertion wasGeneratedBy ECO_0000203 NP222603.RAsswML4jAZ1GvYVxV8G4q2vvHclTUjNBsUKWx8sb3rn0130_provenance.